Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
The National Institute of Infectious Diseases (NIID) said on January 24 that resistant virus mutants have been detected in children who were administered the anti-influenza drug Xofluza (baloxavir marboxil) last December. At the clinical trial stage, mutations of PA protein’s…
To read the full story
Related Article
REGULATORY
- Lilly’s Oral GLP-1 Obesity Drug Heads to Dec. 2 Panel Review, Eyes Japan First
November 19, 2026
- Pharma Prods LDP to Rethink CEA Expansion, Project Team to Compile Proposal
November 19, 2026
- First Pralia Biosimilars Inching Closer to Japan Approval, 5 Products Lined Up
November 19, 2026
- MHLW Drug Supply Monitoring System Hit by Cyberattack, Possible Data Leak
November 19, 2026
- Japan’s FY2027 AMED Budget Requests Top 450 Billion Yen
November 19, 2026





